NeuroBo Pharmaceuticals (NRBO)
NASDAQ:NRBO
US Market
Holding NRBO?
Track your performance easily

NeuroBo Pharmaceuticals (NRBO) Financial Statements

330 Followers

NeuroBo Pharmaceuticals Financial Overview

NeuroBo Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-4.969; its P/E ratio is -0.51; NeuroBo Pharmaceuticals is scheduled to report earnings on November 11, 2024, and the estimated EPS forecast is $-0.82. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Sep 23Jun 23Mar 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT$ -10.22M$ -6.95M$ -3.89M$ -734.00K$ -2.60M
EBITDA$ -10.21M$ -6.95M$ -3.89M-$ -2.60M
Net Income Common Stockholders$ -10.05M$ -6.71M$ -3.82M$ -734.00K$ -2.60M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 27.93M$ 16.00M$ 25.80M$ 28.70M$ 30.80M
Total Assets$ 28.75M$ 17.02M$ 26.43M$ 29.18M$ 31.48M
Total Debt$ 170.00K$ 187.00K$ 65.00K$ 0.00$ 0.00
Net Debt$ -27.76M$ -15.81M$ -25.73M$ -28.70M$ -30.80M
Total Liabilities$ 9.81M$ 6.94M$ 4.88M$ 3.98M$ 10.98M
Stockholders Equity$ 18.94M$ 10.08M$ 21.55M$ 25.20M$ 20.51M
Cash Flow-
Free Cash Flow$ -7.30M$ -6.41M$ -2.85M-$ -2.55M
Operating Cash Flow$ -7.29M$ -6.40M$ -2.81M$ -2.04M$ -2.55M
Investing Cash Flow$ -3.00K$ -5.00K$ -37.00K-$ -4.00K
Financing Cash Flow$ 19.20M--$ -80.00K-
Currency in USD

NeuroBo Pharmaceuticals Earnings and Revenue History

NeuroBo Pharmaceuticals Debt to Assets

NeuroBo Pharmaceuticals Cash Flow

NeuroBo Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis